Japan puts $8M behind nasal TB vax; 1.25 million child study shows no vaccine-autism link;

> Japan's state-backed Innovation Network is leading an ¥845 million ($8.3 million) round of investment in Create Vaccine, a TB vax developer, to fund the creation of a nasal vaccine for adults. Report

> A watered-down attempt to boost vaccination rates has been signed into law in Colorado. More

> Germany has provided Malawi with a €5 million grant to support the country's immunization program. More

> The Medical Affairs Committee of the South Carolina Senate has passed a bill aimed at encouraging parents to get their children vaccinated against human papillomavirus (HPV). More

> The FDA has approved a Campylobacter jejuni vaccine for human trials. Report

> Researchers report that delaying the first measles-mumps-rubella vaccine (MMR) or the first measles-mumps-rubella-varicella vaccine (MMRV) beyond the age of 15 months may more than double a 2-year-old's risk for postvaccination seizures, researchers report. More (reg. req.)

> Administering Merck's ($MRK) rotavirus jab RotaTeq to infants in the neonatal intensive care unit appears to be safe, a new study shows. Report (reg. req.)

> A series of vaccine injections given directly into a pancreatic cancer tumor has been well tolerated and suggests a period of stable disease, according to eesearch from Rutgers Cancer Institute. News

And Finally... A new Australian study of 1.25 million children around the world shows no link between vaccines and autism. More